Reneo Pharmaceuticals Inc (RPHM)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Gregory J. Flesher
Employees:
P.O. BOX 675614, RANCHO SANTA FE, CA 92067
619-733-3852

Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). Our principal executive offices are located at 12230 El Camino Real, Suite 230, San Diego, California 92130, and our telephone number is (858) 283-0280. We also occupy offices in Sandwich, United Kingdom.

Data derived from most recent annual or quarterly report
Market Cap 163.272 Million Shares Outstanding24.405 Million Avg 30-day Volume 30.646 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 17.18 / 6.1 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

View recent insider trading info

Funds Holding RPHM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RPHM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FLESHER GREGORY J. PRESIDENT AND CEO

  • Officer
  • Director
8,000 2021-08-25 1

CRUSE MICHAEL SENIOR VP-CORPORATE OPERATIONS

  • Officer
2,500 2021-08-25 1

JINDAL VINEET R. CHIEF FINANCIAL OFFICER

  • Officer
5,000 2021-08-25 1

JOHNSON WENDY S. CHIEF DEVELOPMENT OFFICER

  • Officer
0 2021-07-14 2

MURALIDHAR BALI

  • Director
2,073,957 2021-07-14 9

NEW ENTERPRISE ASSOCIATES 15, L.P.

NEA PARTNERS 15, L.P.

NEA 15 GP, LLC

BASKETT FOREST

FLORENCE ANTHONY A. JR.

MAKHZOUMI MOHAMAD

MAKOWER JOSHUA

SANDELL SCOTT D

SONSINI PETER W.

  • 10% Owner
4,785,494 2021-04-13 1

GREY MICHAEL G EXECUTIVE CHAIRMAN

  • Officer
  • Director
578,846 2021-04-13 3

NOVO HOLDINGS A/S

  • 10% Owner
3,430,377 2021-04-13 1

O'DONNELL NIALL

  • Director
2,063,713 2021-04-13 2

RIVERVEST VENTURE FUND III, L.P.

RIVERVEST VENTURE FUND III (OHIO), L.P.

RIVERVEST VENTURE FUND IV, L.P.

  • 10% Owner
No longer subject to file 2021-04-09 1

MATHERS EDWARD T

  • Director
14,000 2021-04-08 1

SELTZER STACEY DENENBERG

  • Director
14,000 2021-04-08 1

HARRISON KENNETH PH.D.

  • Director
0 2021-04-08 2

CARDON LON

  • Director
14,000 2021-04-08 1

HALL ASHLEY CHIEF DEVELOPMENT OFFICER

  • Officer
0 2020-10-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 22:15:03 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 21:45:03 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 21:15:03 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 20:45:03 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 20:15:03 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 19:45:04 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 19:15:03 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 18:45:02 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 18:15:03 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 17:45:03 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 17:15:03 UTC -0.9152 0.9852 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 16:45:02 UTC -0.9524 1.0224 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 16:15:03 UTC -0.9524 1.0224 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 15:45:03 UTC -0.9524 1.0224 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 15:15:03 UTC -0.9524 1.0224 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 14:45:02 UTC -1.2286 1.2986 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 14:15:03 UTC -1.2286 1.2986 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 13:45:03 UTC -1.2286 1.2986 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 13:15:03 UTC -1.2286 1.2986 9000
RENEO PHARMACEUTICALS INC RPHM 2021-10-25 12:45:04 UTC -1.2286 1.2986 4000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments